Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02748668
  4. Details
NCT02748668 Clinical Trial

Extracorporeal Membrane Oxygenation (ECMO): Blood Cells

Extracorporeal Membrane Oxygenation Clinical Trial

Official title:
Extracorporeal Membrane Oxygenation: Blood Cells

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02748668
Other study ID # 2014-255
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 20, 2015
Est. completion date April 25, 2023

Study information
Verified date June 2023
Source Spectrum Health Hospitals
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.

Recruitment information / eligibility
Status Completed
Enrollment 371
Est. completion date April 25, 2023
Est. primary completion date April 25, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility ECMO group: Inclusion Criteria: - Greater than or equal to 18 years of age - Subject presents to the CTICU at Butterworth Campus, Spectrum Health and is critically ill in the ICU needing ECMO therapy. Exclusion Criteria: - Subject is less than 18 years of age - Known prisoner Control Subjects: Inclusion Criteria - Greater than 18 years of age - Without any known cardiovascular, lung, or autoimmune disease. Exclusion Criteria: - Less than or equal to 18 years of age - Known cardiovascular, lung, or autoimmune disease

Study Design

Related Conditions & MeSH terms

  • Extracorporeal Membrane Oxygenation

Intervention

Other:
• Blood specimen collection

Locations
Country Name City State
United States Spectrum Health Grand Rapids Michigan

Sponsors (2)
Lead Sponsor Collaborator
Spectrum Health Hospitals Van Andel Research Institute

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary All cause mortality 1 year
See also
  Status Clinical Trial Phase
Completed NCT03685383 - Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation N/A
Not yet recruiting NCT05106491 - Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients N/A
Recruiting NCT05699005 - Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO Phase 1
Recruiting NCT05444764 - PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS
Completed NCT05038943 - Evaluation of Safety and Effectiveness of The SherpaPak in Donation After Circulatory Death Heart Transplantation N/A
Not yet recruiting NCT05341687 - Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
Suspended NCT04385771 - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation N/A
Recruiting NCT03766282 - Pharmacokinetics in Extracorporeal Membrane Oxygenation
Completed NCT03355625 - Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
Completed NCT01521195 - Oxygen Consumption In Critically Ill Children N/A
Recruiting NCT04620070 - ON-SCENE Initiation of Extracorporeal CardioPulmonary Resuscitation During Refractory Out-of-Hospital Cardiac Arrest N/A
Recruiting NCT06062212 - Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO
Recruiting NCT05730114 - Monitoring Antiplatelet Drugs in Cardiac Arrest Patients
Completed NCT05154071 - Impact of the Implementation of a Referral Veno-venous Extracorporeal Membrane Oxygenation Centre on Mortality
Recruiting NCT04536272 - Reduced Anticoagulation Targets in ECLS (RATE) Phase 3
Completed NCT05693051 - Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
Completed NCT03764319 - Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and ECMO N/A
Recruiting NCT05762029 - Treatment of Extracorporeal Membrane Oxygenation in Severe Poisoning
Completed NCT02995811 - Characterising Changes in Muscle Quantity and Quality in Patients Requiring ECMO Oxygen During Critical Illness
Recruiting NCT04754854 - Reduction of Blood Recirculation in Veno-Venous ECMO